• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荷兰心血管疾病患者为何接受 Q 热疫苗接种?

Why did patients with cardiovascular disease in the Netherlands accept Q fever vaccination?

机构信息

Municipal Public Health Service Rotterdam-Rijnmond, 3000 LP Rotterdam, The Netherlands.

出版信息

Vaccine. 2012 May 14;30(23):3369-75. doi: 10.1016/j.vaccine.2012.03.056. Epub 2012 Apr 1.

DOI:10.1016/j.vaccine.2012.03.056
PMID:22475862
Abstract

This study examines patient's reasons for accepting Q fever vaccination, including risk perception, feelings of doubt, social influence, information-seeking behavior, preventive measures taken, and perceptions regarding received information and governmental action. Data was obtained from exit interviews conducted after Q fever vaccination, between January and April 2011. A total of 413 patients with specific cardiovascular conditions in the Netherlands participated in exit interviews; 70% were older than 60 years. Most reported reasons for accepting Q fever vaccination were: "I am at an increased risk for developing (chronic) Q fever" (69%) and "my general practitioner recommends Q fever vaccination for me" (34%). The majority (86%) reported a high perceived severity of Q fever, and only 6% felt vulnerable to Q fever after vaccination. One-third had doubts about getting vaccinated, primarily related to fears of side effects and practical barriers. Fifty-two percent solicited advice from their social networks; of these, 67% reported influence on their vaccination decision. General practitioners and family were the most reported sources of advice. Thirty percent actively sought information about Q fever vaccination. Twenty-two percent of all respondents had taken other preventive measures, such as avoiding contact with goats and sheep (74%), and cancelling or postponing visits to Q fever-affected areas (36%). Almost one-half of all respondents reported negative feelings regarding governmental action to control Q fever. Significant differences were observed regarding feelings of doubt, information-seeking behavior, perceived vulnerability, preventive measures taken, and perceptions regarding received information and governmental action regarding gender, age, educational level, and/or employment status. Vaccination decision-making may differ among socio-demographic subgroups. When preparing future vaccination campaigns, it is important to obtain greater insight into these differences and take these aspects into account in risk communication strategies by tailoring information to specific target groups.

摘要

本研究考察了患者接受 Q 热疫苗接种的原因,包括风险感知、疑虑感、社会影响、信息搜索行为、采取的预防措施以及对所收到信息和政府行动的看法。数据来自 2011 年 1 月至 4 月期间 Q 热疫苗接种后的退出访谈。荷兰共有 413 名患有特定心血管疾病的患者参加了退出访谈;70%的人年龄超过 60 岁。大多数人报告接受 Q 热疫苗接种的原因是:“我有患(慢性)Q 热的风险增加”(69%)和“我的全科医生建议我接种 Q 热疫苗”(34%)。大多数人(86%)报告 Q 热的严重程度很高,只有 6%的人在接种疫苗后感到易感染 Q 热。三分之一的人对接种疫苗有疑虑,主要与对副作用和实际障碍的担忧有关。52%的人向他们的社交网络寻求建议;其中,67%的人表示这对他们的接种决定有影响。全科医生和家人是最常被提及的建议来源。30%的人主动寻找有关 Q 热疫苗接种的信息。22%的受访者采取了其他预防措施,如避免接触山羊和绵羊(74%),以及取消或推迟前往 Q 热疫区的行程(36%)。几乎一半的受访者对政府控制 Q 热的行动表示不满。在疑虑感、信息搜索行为、感知脆弱性、采取的预防措施以及对所收到信息和政府行动的看法方面,性别、年龄、教育水平和/或就业状况存在显著差异。疫苗接种决策可能因社会人口统计学亚组而异。在为未来的疫苗接种活动做准备时,重要的是要更深入地了解这些差异,并在风险沟通策略中考虑到这些方面,根据特定目标群体定制信息。

相似文献

1
Why did patients with cardiovascular disease in the Netherlands accept Q fever vaccination?荷兰心血管疾病患者为何接受 Q 热疫苗接种?
Vaccine. 2012 May 14;30(23):3369-75. doi: 10.1016/j.vaccine.2012.03.056. Epub 2012 Apr 1.
2
Pandemic influenza A (H1N1) vaccination in The Netherlands: parental reasoning underlying child vaccination choices.荷兰大流行性流感 A(H1N1)疫苗接种:儿童疫苗接种选择背后的父母推理。
Vaccine. 2011 Aug 26;29(37):6226-35. doi: 10.1016/j.vaccine.2011.06.075. Epub 2011 Jul 5.
3
Risks, trust and knowledge: determinants of pregnant women's decisions regarding participation in a future Q fever screening and treatment program during a large epidemic in The Netherlands.风险、信任和知识:荷兰大规模 Q 热流行期间,决定孕妇未来是否参与 Q 热筛查和治疗计划的因素。
Prenat Diagn. 2011 Aug;31(8):814-20. doi: 10.1002/pd.2772. Epub 2011 Jun 30.
4
Adverse events and association with age, sex and immunological parameters of Q fever vaccination in patients at risk for chronic Q fever in the Netherlands 2011.2011年荷兰慢性Q热风险患者中Q热疫苗接种的不良事件及其与年龄、性别和免疫参数的关联
Vaccine. 2014 Nov 20;32(49):6622-30. doi: 10.1016/j.vaccine.2014.09.061.
5
Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.5个欧洲国家的流感疫苗接种覆盖率:基于人群的2002/03、2003/04和2004/05季节横断面分析。
Infection. 2007 Oct;35(5):308-19. doi: 10.1007/s15010-007-6218-5. Epub 2007 Sep 20.
6
Differences in perception of dysentery and enteric fever and willingness to receive vaccines among rural residents in China.中国农村居民对痢疾和伤寒的认知差异以及接种疫苗的意愿
Vaccine. 2006 Jan 30;24(5):561-71. doi: 10.1016/j.vaccine.2005.08.060. Epub 2005 Aug 30.
7
Coverage of the 2011 Q fever vaccination campaign in the Netherlands, using retrospective population-based prevalence estimation of cardiovascular risk-conditions for chronic Q fever.荷兰2011年Q热疫苗接种活动的覆盖情况,采用基于人群回顾性患病率估计慢性Q热的心血管风险状况。
PLoS One. 2015 Apr 24;10(4):e0123570. doi: 10.1371/journal.pone.0123570. eCollection 2015.
8
Australia's national Q fever vaccination program.澳大利亚全国Q热疫苗接种计划。
Vaccine. 2009 Mar 23;27(14):2037-41. doi: 10.1016/j.vaccine.2009.02.007. Epub 2009 Feb 12.
9
Effectiveness of the Q fever vaccine: a meta-analysis.Q 热疫苗的有效性:荟萃分析。
Vaccine. 2011 Jan 10;29(3):395-8. doi: 10.1016/j.vaccine.2010.11.008. Epub 2010 Nov 19.
10
[The fight against Q fever. Experts about the cleanup and the future of the goat husbandry in the Netherlands].[抗击Q热。荷兰专家谈山羊养殖的清理及未来]
Tijdschr Diergeneeskd. 2010 Feb 1;135(3):102-4.

引用本文的文献

1
Role of COVID-19 Anxiety and Community Risk Factors on Physical Distancing Practice.新冠焦虑及社区风险因素对保持社交距离行为的作用
Behav Sci (Basel). 2022 Apr 16;12(4):110. doi: 10.3390/bs12040110.
2
How far are we from a medication use process aiming at well-informed adherent patients with long-term medications in Finland? Qualitative study.在芬兰,我们距离实现让长期用药的患者知情并遵从医嘱的药物使用流程还有多远?定性研究。
BMJ Open. 2020 Jun 21;10(6):e036526. doi: 10.1136/bmjopen-2019-036526.
3
Trends in the receipt of medicines information among Finnish adults in 1999-2014: a nationwide repeated cross-sectional survey.
1999-2014 年芬兰成年人接受药物信息的趋势:一项全国性重复横断面调查。
BMJ Open. 2019 Jun 14;9(6):e026377. doi: 10.1136/bmjopen-2018-026377.
4
Coverage of the 2011 Q fever vaccination campaign in the Netherlands, using retrospective population-based prevalence estimation of cardiovascular risk-conditions for chronic Q fever.荷兰2011年Q热疫苗接种活动的覆盖情况,采用基于人群回顾性患病率估计慢性Q热的心血管风险状况。
PLoS One. 2015 Apr 24;10(4):e0123570. doi: 10.1371/journal.pone.0123570. eCollection 2015.
5
Q fever in the Netherlands: public perceptions and behavioral responses in three different epidemiological regions: a follow-up study.荷兰的Q热:三个不同流行地区的公众认知与行为反应:一项随访研究
BMC Public Health. 2014 Mar 20;14:263. doi: 10.1186/1471-2458-14-263.